People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Preceptis Medical, Inc. | — | Healthtech | Series A | $21.3M | $8.3M | 2017 |
David Overman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Overman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Anderson | 1 | 14 |
| Mark Wagner | 1 | 9 |
| BUZZ BENSON | 1 | 8 |
| John Seaberg | 1 | 5 |
| JOE DELGADO | 1 | 3 |
| Michael Dale | 1 | 3 |
| Christopher Geyen | 1 | 3 |
| Feng Jiang | 1 | 2 |
| Zhaohua Yuan | 1 | 1 |
| Michael Loushin | 1 | 1 |
| Toni Baraga | 1 | 1 |
| Thomas Vettel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.